Patents by Inventor Byeoung Kyu Choi

Byeoung Kyu Choi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds derived from and uses thereof
    Patent number: 11878984
    Abstract: The present invention relates to new compounds derived from marine actinomycetes Streptomyces, and the new compound according to the present invention has an inhibitory effect of NO production on BV-2 microglia stimulated with LPS, and thus can be utilized for the prevention and treatment of neuroinflammatory diseases.
    Type: Grant
    Filed: June 3, 2019
    Date of Patent: January 23, 2024
    Assignee: KOREA INSTITUTE OF OCEAN SCIENCE & TECHNOLOGY
    Inventors: Hee Jae Shin, Byeoung Kyu Choi, Hwa Sun Lee, Hyi Seung Lee, Yeon Ju Lee, Jong Seok Lee, Ji Hoon Lee
  • Rhamnolipid compounds and use thereof
    Patent number: 11286273
    Abstract: Disclosed are a novel rhamnolipid compound, an optical isomer thereof, or a pharmaceutically acceptable salt thereof in the present disclosure. The novel rhamnolipid compound, the optical isomer thereof, or the pharmaceutically acceptable salt thereof selectively exhibits cytotoxicity to human cancer cell lines, thereby inhibiting the growth of cancer cells, and thus has particularly excellent preventive or therapeutic effects against the above-mentioned types of cancers.
    Type: Grant
    Filed: March 8, 2019
    Date of Patent: March 29, 2022
    Assignee: KOREA INSTITUTE OF OCEAN SCIENCE & TECHNOLOGY
    Inventors: Hee Jae Shin, Byeoung Kyu Choi, Hwa Sun Lee, Hyi Seung Lee, Yeon Ju Lee, Jong Seok Lee, Ji Hoon Lee, Chan Hong Park
  • NEW COMPOUND DERIVED FROM STREPTOMYCES AND USE THEREOF
    Publication number: 20220033413
    Abstract: The present invention relates to new compounds derived from marine actinomycetes Streptomyces, and the new compound according to the present invention has an inhibitory effect of NO production on BV-2 microglia stimulated with LPS, and thus can be utilized for the prevention and treatment of neuroinflammatory diseases.
    Type: Application
    Filed: June 3, 2019
    Publication date: February 3, 2022
    Applicant: KOREA INSTITUTE OF OCEAN SCIENCE & TECHNOLOGY
    Inventors: Hee Jae SHIN, Byeoung Kyu CHOI, Hwa Sun LEE, Hyi Seung LEE, Yeon Ju LEE, Jong Seok LEE, Ji Hoon LEE
  • NOVEL RHAMNOLIPID COMPOUNDS AND USE THEREOF
    Publication number: 20210355151
    Abstract: Disclosed are a novel rhamnolipid compound, an optical isomer thereof, or a pharmaceutically acceptable salt thereof in the present disclosure. The novel rhamnolipid compound, the optical isomer thereof, or the pharmaceutically acceptable salt thereof selectively exhibits cytotoxicity to human cancer cell lines, thereby inhibiting the growth of cancer cells, and thus has particularly excellent preventive or therapeutic effects against the above-mentioned types of cancers.
    Type: Application
    Filed: March 8, 2019
    Publication date: November 18, 2021
    Applicant: KOREA INSTITUTE OF OCEAN SCIENCE & TECHNOLOGY
    Inventors: Hee Jae Shin, Byeoung Kyu Choi, Hwa Sun Lee, Hyi Seung Lee, Yeon Ju Lee, Jong Seok Lee, Ji Hoon Lee, Chan Hong Park